Please assess the completion status of the following clinical trial:

Trial Title: Chemopreventive Therapy for Malaria in Ugandan Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 4 -5 months~2. Confirmed HIV status of biological mother~3. Negative HIV DNA PCR test at time of enrollment for infants born to HIV-infected mothers~4. Infants born to HIV-infected mothers must be breastfeeding~5. Residency within 30km of the study clinic~6. Agreement to come to the study clinic for any febrile episode or other illness and avoid medications given outside the study protocol~7. Provision of informed consent by parent/guardian~Exclusion Criteria:~1. History of allergy or sensitivity to TS, SP, or DP~2. Active medical problem requiring in-patient evaluation at the time of screening~3. Intention of moving more that 30km from the study clinic during the follow-up period~4. Chronic medical condition (i.e. malignancy) requiring frequent medical attention~5. Living in the same household as a previously enrolled study participant~6. QTc interval \> 450 msec~7. Other clinically significant ECG abnormalities such as arrhythmia, ischemia, or evidence of heart failure~8. Family history of Long QT syndrome~9. Current use of drugs that prolong the QT interval

- Gender: ALL
- Minimum Age: 4 Months
- Maximum Age: 5 Months
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).